Saudi Journal of Kidney Diseases and Transplantation

RENAL DATA FROM ASIA-AFRICA
Year
: 2013  |  Volume : 24  |  Issue : 2  |  Page : 403--407

Outcome of deceased donor renal transplantation - A single-center experience from developing country


Himanshu V Patel1, Vivek B Kute1, Ghanshyam H Ghelani1, Aruna V Vanikar2, Pankaj R Shah1, Manoj R Gumber1, Hargovind L Trivedi1 
1 Department of Nephrology and Clinical Transplantation, Institute of Kidney Diseases and Research Center, Dr. H. L. Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, India
2 Department of Nephrology and Clinical Transplantation; Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, Institute of Kidney Diseases and Research Center, Dr. H. L. Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, India

Correspondence Address:
Himanshu V Patel
Department of Nephrology and Clinical Transplantation, IKDRC-ITS, Civil Hospital Campus, Asarwa, Ahmedabad 380016, Gujarat
India

Renal transplantation (RTx) is considered as the best therapeutic modality for patient suffering from end-stage renal disease (ESRD). Dearth of donor kidneys is a major problem everywhere, and deceased donor renal transplantation (DDRTx) is seen as at least a partial solution. Even so, DDRTx accounts for only less than 4% of RTx in India. We report our 6-year single-center experience on DDRTx vis-à-vis patient/graft survival, graft function in terms of serum creatinine (SCr), rejection episodes, and delayed graft function (DGF). Between January 2005 and March 2011, 236 DDRTx were performed. Majority of the donors were those with brain death due to road traffic/cerebrovascular accidents. The commonest recipient diseases leading to ESRD were chronic glomerulonephritis (42.8%), diabetes (12.7%), and hypertension (10.6%). Mean recipient age was 36.2 ± 14.2 years; 162 were males and 74 were females. Mean donor age was 45.3 ± 17.13 years; 144 were males and 92 were females. Mean dialysis duration pre-transplantation was 18.5 ± 2.5 months. All recipients received single-dose rabbit-anti-thymocyte globulin induction and steroids, calcinueurin inhibitor, and mycophenolate mofetil/azathioprine for maintenance immunosuppression. Delayed graft function was observed in 29.6% patients and 22% had biopsy-proven acute rejection. Over the mean follow-up of 2.18 ± 1.75 years, patient and graft survival rates were 74.57% and 86.8%, respectively, with mean SCr of 1.42 ± 0.66 mg%. DDRTx achieves acceptable graft function with patient/graft survival, encouraging the use of this approach in view of organ shortage.


How to cite this article:
Patel HV, Kute VB, Ghelani GH, Vanikar AV, Shah PR, Gumber MR, Trivedi HL. Outcome of deceased donor renal transplantation - A single-center experience from developing country.Saudi J Kidney Dis Transpl 2013;24:403-407


How to cite this URL:
Patel HV, Kute VB, Ghelani GH, Vanikar AV, Shah PR, Gumber MR, Trivedi HL. Outcome of deceased donor renal transplantation - A single-center experience from developing country. Saudi J Kidney Dis Transpl [serial online] 2013 [cited 2022 May 16 ];24:403-407
Available from: https://www.sjkdt.org/article.asp?issn=1319-2442;year=2013;volume=24;issue=2;spage=403;epage=407;aulast=Patel;type=0